• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

随机起始孕激素预处理促排卵在生育力保存中的应用。

Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation.

机构信息

Department of Obstetrics and Gynecology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama, 350-3550, Japan.

出版信息

J Ovarian Res. 2022 Jan 4;15(1):2. doi: 10.1186/s13048-021-00935-5.

DOI:10.1186/s13048-021-00935-5
PMID:34983605
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8725433/
Abstract

BACKGROUND

Progestin-primed ovarian stimulation (PPOS) has been used in infertility cases in recent years, and several reports have stated that it has oocyte collection results similar to those of gonadotropin-releasing hormone antagonist (GnRH-ant) protocol. For emergency fertility preservation, random-start ovarian stimulation is usually recommended. Therefore we compared the clinical outcomes of random-start PPOS with those of conventional random-start GnRH-ant protocols in fertility-preserving cases.

METHODS

We retrospectively examined 86 cycles of oocyte collection, of which 56 were random-start GnRH-ant and 30 were random-start PPOS for fertility preservation at our hospital between January 2016 and April 2021. The primary outcome was the number of mature oocytes per cycle. The secondary outcome was the number of vitrified blastocysts per cycle for embryo freezing cases.

RESULTS

No significant differences were noted in the number of days of stimulation, total dose of gonadotropin preparation, and the number of mature oocytes and vitrified blastocysts. The number of hospital visits for monitoring was significantly lower in the PPOS group. The start of menstruation before oocyte collection was significantly less in the PPOS group.

CONCLUSIONS

Random-start PPOS and GnRH-ant were similar in oocyte collection results. PPOS can reduce the number of hospital visits, thus reducing patient stress. PPOS at the start of the luteal phase can prevent the start of menstruation during ovarian stimulation.

摘要

背景

近年来,孕激素预处理的卵巢刺激(PPOS)已应用于不孕病例,有几项报告称其取卵结果与促性腺激素释放激素拮抗剂(GnRH-ant)方案相似。对于紧急生育力保存,通常推荐随机起始卵巢刺激。因此,我们比较了随机起始 PPOS 与常规随机起始 GnRH-ant 方案在生育力保存病例中的临床结局。

方法

我们回顾性分析了 2016 年 1 月至 2021 年 4 月期间在我院进行的 86 个卵母细胞采集周期,其中 56 个为随机起始 GnRH-ant,30 个为随机起始 PPOS 用于生育力保存。主要结局是每个周期的成熟卵母细胞数。对于胚胎冷冻病例,次要结局是每个周期的可冷冻囊胚数。

结果

两组在刺激天数、促性腺激素制剂总剂量、成熟卵母细胞和可冷冻囊胚数方面无显著差异。PPOS 组的监测就诊次数显著减少。PPOS 组在卵母细胞采集前的月经开始时间显著减少。

结论

随机起始 PPOS 和 GnRH-ant 的取卵结果相似。PPOS 可减少就诊次数,从而减轻患者的压力。黄体期起始 PPOS 可防止卵巢刺激期间月经开始。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1003/8725433/7e182c97258f/13048_2021_935_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1003/8725433/7e182c97258f/13048_2021_935_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1003/8725433/7e182c97258f/13048_2021_935_Fig1_HTML.jpg

相似文献

1
Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation.随机起始孕激素预处理促排卵在生育力保存中的应用。
J Ovarian Res. 2022 Jan 4;15(1):2. doi: 10.1186/s13048-021-00935-5.
2
Outcomes and cost-effectiveness comparisons of progestin-primed ovarian stimulation, GnRH antagonist protocol, and luteal phase stimulation for fertility preservation.孕激素预处理促排卵、促性腺激素释放激素拮抗剂方案和黄体期刺激用于生育力保存的结局和成本效益比较。
Int J Gynaecol Obstet. 2023 Nov;163(2):645-650. doi: 10.1002/ijgo.14903. Epub 2023 Jun 2.
3
Comparison of cumulative live birth rates between progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in different populations.不同人群中孕激素预处理的卵巢刺激方案与促性腺激素释放激素拮抗剂方案的累积活产率比较。
Front Endocrinol (Lausanne). 2023 Apr 18;14:1117513. doi: 10.3389/fendo.2023.1117513. eCollection 2023.
4
Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.多囊卵巢综合征患者中采用灵活 GnRH 拮抗剂方案与孕激素预刺激卵巢刺激(PPOS)方案:临床结局和卵巢反应的比较。
Curr Med Sci. 2019 Jun;39(3):431-436. doi: 10.1007/s11596-019-2055-x. Epub 2019 Jun 17.
5
Comparison of the pregnancy outcomes of progestin-primed vs. antagonist ovarian stimulation in patients with poor ovarian response: a retrospective study.孕激素预处理与拮抗剂方案卵巢刺激在卵巢低反应患者中的妊娠结局比较:一项回顾性研究。
Gynecol Endocrinol. 2024 May 6;40(1):2352133. doi: 10.1080/09513590.2024.2352133. Epub 2024 May 15.
6
Oocyte competence is comparable between progestin primed ovarian stimulation with Norethisterone acetate (NETA-PPOS) and GnRH-antagonist protocols: A matched case-control study in PGT-A cycles.孕激素预处理卵巢刺激(NETA-PPOS)和 GnRH 拮抗剂方案中卵母细胞成熟能力相当:PGT-A 周期中的匹配病例对照研究。
Eur J Obstet Gynecol Reprod Biol. 2024 Mar;294:4-10. doi: 10.1016/j.ejogrb.2023.12.035. Epub 2023 Dec 25.
7
Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols.内异症患者生育力保存的结局:孕激素预刺激与拮抗剂方案的比较。
J Ovarian Res. 2020 Feb 13;13(1):18. doi: 10.1186/s13048-020-00620-z.
8
Non-inferiority of progestin-primed ovarian stimulation versus GnRH antagonist protocol: A propensity score-weighted analysis.孕激素预处理的卵巢刺激与 GnRH 拮抗剂方案的非劣效性:倾向评分加权分析。
J Formos Med Assoc. 2024 Apr;123(4):523-529. doi: 10.1016/j.jfma.2023.12.008. Epub 2023 Dec 12.
9
Progestin primed ovarian stimulation using dydrogesterone from day 7 of the cycle onwards in oocyte donation cycles: a longitudinal study.在供卵周期中,从周期第 7 天开始使用地屈孕酮进行孕激素预刺激:一项纵向研究。
Reprod Biomed Online. 2024 May;48(5):103732. doi: 10.1016/j.rbmo.2023.103732. Epub 2023 Nov 20.
10
Progestin-primed ovarian stimulation versus GnRH antagonist protocol in poor responders: Risk of premature LH surge and outcome of oocyte retrieval.孕激素预处理的卵巢刺激方案与GnRH拮抗剂方案用于卵巢低反应者:过早促黄体生成素峰的风险及取卵结果
J Formos Med Assoc. 2023 Jan;122(1):29-35. doi: 10.1016/j.jfma.2022.08.023. Epub 2022 Sep 16.

引用本文的文献

1
A comparison of the effects of progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in assisted reproductive technology: a systematic review and meta-analysis.孕激素预处理卵巢刺激方案与促性腺激素释放激素拮抗剂方案在辅助生殖技术中的效果比较:一项系统评价和荟萃分析
J Assist Reprod Genet. 2025 Aug 7. doi: 10.1007/s10815-025-03612-4.
2
Serum concentrations of medroxyprogesterone acetate were undetectable on OPU+5 days and had no effect on the serum progesterone level in patients undergoing the progestin-primed ovarian stimulation protocol.在取卵后5天时,醋酸甲羟孕酮的血清浓度无法检测到,且对接受孕激素预处理卵巢刺激方案的患者的血清孕酮水平没有影响。
Front Endocrinol (Lausanne). 2025 May 14;16:1490839. doi: 10.3389/fendo.2025.1490839. eCollection 2025.
3

本文引用的文献

1
Dydrogesterone-primed ovarian stimulation is an effective alternative to gonadotropin-releasing hormone antagonist protocol for freeze-all cycles in polycystic ovary syndrome.地屈孕酮预处理的卵巢刺激是多囊卵巢综合征全胚冷冻周期中促性腺激素释放激素拮抗剂方案的有效替代方案。
J Obstet Gynaecol Res. 2020 Aug;46(8):1403-1411. doi: 10.1111/jog.14267. Epub 2020 Jun 4.
2
Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation.比较使用孕激素或 GnRH 拮抗剂预防卵巢刺激中黄体生成素峰时胚胎中整倍体率。
Hum Reprod. 2020 Jun 1;35(6):1325-1331. doi: 10.1093/humrep/deaa068.
3
Meeting proceedings: International Society for Fertility Preservation Tokyo, 15-17 November, 2024.会议纪要:国际生育力保存协会东京会议,2024年11月15 - 17日。
J Assist Reprod Genet. 2025 Apr 23. doi: 10.1007/s10815-025-03478-6.
4
The construction of machine learning-based predictive models for high-quality embryo formation in poor ovarian response patients with progestin-primed ovarian stimulation.基于孕激素预处理卵巢刺激的卵巢反应不良患者中高质量胚胎形成的机器学习预测模型的构建。
Reprod Biol Endocrinol. 2024 Jul 10;22(1):78. doi: 10.1186/s12958-024-01251-5.
5
Fertility preservation after gonadotoxic treatments for cancer and autoimmune diseases.癌症和自身免疫性疾病的性腺毒性治疗后的生育力保存。
J Ovarian Res. 2023 Aug 10;16(1):159. doi: 10.1186/s13048-023-01250-x.
6
Progestin-primed ovarian stimulation for fertility preservation in women with cancer: A comparative study.孕激素预处理的卵巢刺激在癌症患者生育力保存中的应用:一项比较研究。
PLoS One. 2023 Mar 28;18(3):e0280238. doi: 10.1371/journal.pone.0280238. eCollection 2023.
Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols.
内异症患者生育力保存的结局:孕激素预刺激与拮抗剂方案的比较。
J Ovarian Res. 2020 Feb 13;13(1):18. doi: 10.1186/s13048-020-00620-z.
4
Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing Fertilization Treatment: A Randomized Controlled Trial.孕激素与促性腺激素释放激素拮抗剂预防低反应者体外受精治疗中过早促黄体生成素峰的随机对照试验
Front Endocrinol (Lausanne). 2019 Nov 22;10:796. doi: 10.3389/fendo.2019.00796. eCollection 2019.
5
Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.绝经激素治疗的类型和时机与乳腺癌风险:全球流行病学证据的个体参与者荟萃分析。
Lancet. 2019 Sep 28;394(10204):1159-1168. doi: 10.1016/S0140-6736(19)31709-X. Epub 2019 Aug 29.
6
Comparison of a novel flexible progestin primed ovarian stimulation protocol and the flexible gonadotropin-releasing hormone antagonist protocol for assisted reproductive technology.新型孕激素预处理的卵巢刺激方案与促性腺激素释放激素拮抗剂方案在辅助生殖技术中的比较。
Fertil Steril. 2019 Oct;112(4):677-683. doi: 10.1016/j.fertnstert.2019.06.009. Epub 2019 Jul 29.
7
New trial of progestin-primed ovarian stimulation using dydrogesterone versus a typical GnRH antagonist regimen in assisted reproductive technology.在辅助生殖技术中,使用地屈孕酮进行孕激素预处理的卵巢刺激与典型促性腺激素释放激素拮抗剂方案的新试验。
Arch Gynecol Obstet. 2018 Sep;298(3):663-671. doi: 10.1007/s00404-018-4856-8. Epub 2018 Aug 1.
8
New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.地屈孕酮在 IVF 促性腺激素预备周期中的新应用:一项纳入 516 个首次 IVF/ICSI 周期的随机对照试验。
Hum Reprod. 2018 Feb 1;33(2):229-237. doi: 10.1093/humrep/dex367.
9
Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.随机启动卵巢刺激用于在性腺毒性癌症治疗前希望保留生育能力的女性的卵母细胞或胚胎冷冻保存。
Curr Pharm Biotechnol. 2017 Nov 10;18(8):609-613. doi: 10.2174/1389201018666170808122531.
10
Is it the egg or the endometrium? Elevated progesterone on day of trigger is not associated with embryo ploidy nor decreased success rates in subsequent embryo transfer cycles.是卵子还是子宫内膜的问题?扳机日孕酮水平升高与胚胎倍性无关,也不会降低后续胚胎移植周期的成功率。
J Assist Reprod Genet. 2016 Sep;33(9):1169-74. doi: 10.1007/s10815-016-0752-y. Epub 2016 Jun 4.